Canada markets open in 33 minutes

Chemomab Therapeutics Ltd. (CMMB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.2200+0.1500 (+14.02%)
At close: 04:00PM EDT
1.2000 -0.02 (-1.64%)
Pre-Market: 08:27AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
14,606
18,381
16,977
6,334
4,684
Selling General and Administrative
5,852
7,078
11,556
6,033
1,288
Total Operating Expenses
20,458
25,459
28,533
12,367
5,972
Operating Income or Loss
-20,458
-25,459
-28,533
-12,367
-5,972
Income Before Tax
-19,357
-24,221
-28,180
-12,478
-5,951
Income Tax Expense
-21
0
-534
0
-
Income from Continuing Operations
-19,336
-24,221
-27,646
-12,478
-5,951
Net Income
-19,336
-24,221
-27,646
-12,478
-5,951
Net Income available to common shareholders
-19,336
-24,221
-27,646
-12,478
-5,951
Basic EPS
-2.94
-2.06
-2.42
-1.20
-0.54
Diluted EPS
-2.94
-2.06
-2.42
-1.20
-0.54
Basic Average Shares
11,210
11,750
11,379
10,373
11,003
Diluted Average Shares
11,210
11,750
11,379
10,373
11,003